Neuroscience
From The Boston Globe:
After a coma
Comebacks are slow and patchy, and almost never miraculous
By Carey Goldberg
The Boston Globe
July 5, 2005
[ ... Read the article ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Dementia And Adult Lifestyle
Work longer, stay sharper Working beyond normal retirement age appears to keep dementia at bay The Boston Globe 27 July 2009 Read article...
- Business World: Biogen Idec, Protein Design Labs, & Daclizumab
From The Boston Globe:Biogen cuts deal to refill drug lineup Biotech to pay Calif. firm for rights to help develop MS treatment, 2 others By Jeffrey Krasner, Globe Staff The Boston Globe August 3, 2005 Making good on a promise to use a war chest of...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab)
From today's Boston Globe:Biogen MS drug gets lift from reports Medical journal suggests Tysabri may make a return By Jeffrey Krasner The Boston Globe 10 June 2005 Biogen Idec Inc.'s drug Tysabri might be safely given to multiple sclerosis patients...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) (cont.)
Additional information in follow-up to this morning's Boston Globe report, from Bloomberg:Elan, Biogen Decline on Report of New Tysabri Illness June 2 (Bloomberg) -- Shares of Elan Corp. and Biogen Idec Inc. tumbled after a fourth possible case of...
- What's Happening In Neuroscience?
Yesterday's Sunday magazine in the Boston Globe included a decent feature article about advances in the neurosciences: Brain Power By Pamela Ferdinand The Boston Globe 05 December 2004 [ ... Read the article ... ]...
Neuroscience
Coma Dissipation
From The Boston Globe:
After a coma
Comebacks are slow and patchy, and almost never miraculous
By Carey Goldberg
The Boston Globe
July 5, 2005
[ ... Read the article ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Dementia And Adult Lifestyle
Work longer, stay sharper Working beyond normal retirement age appears to keep dementia at bay The Boston Globe 27 July 2009 Read article...
- Business World: Biogen Idec, Protein Design Labs, & Daclizumab
From The Boston Globe:Biogen cuts deal to refill drug lineup Biotech to pay Calif. firm for rights to help develop MS treatment, 2 others By Jeffrey Krasner, Globe Staff The Boston Globe August 3, 2005 Making good on a promise to use a war chest of...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab)
From today's Boston Globe:Biogen MS drug gets lift from reports Medical journal suggests Tysabri may make a return By Jeffrey Krasner The Boston Globe 10 June 2005 Biogen Idec Inc.'s drug Tysabri might be safely given to multiple sclerosis patients...
- Business World: Biogen Idec, Elan, & Tysabri (natalizumab) (cont.)
Additional information in follow-up to this morning's Boston Globe report, from Bloomberg:Elan, Biogen Decline on Report of New Tysabri Illness June 2 (Bloomberg) -- Shares of Elan Corp. and Biogen Idec Inc. tumbled after a fourth possible case of...
- What's Happening In Neuroscience?
Yesterday's Sunday magazine in the Boston Globe included a decent feature article about advances in the neurosciences: Brain Power By Pamela Ferdinand The Boston Globe 05 December 2004 [ ... Read the article ... ]...